MMP9 and central nervous system cancer: Similarly, MMP2 and MMP9 function as the key mediator of VM in glioma, while the suppression of Tenascin‐c attenuates AKT phosphorylation, and downregulates MMP2 and MMP9 expression, thus repressing VM in gliomas.52